Drug Type Small molecule drug |
Synonyms Naltrexone/fluoxetine, OREX-004 |
Target |
Action antagonists, inhibitors |
Mechanism Opioid receptors antagonists(Opioid receptors antagonists), SERT inhibitors(Serotonin transporter inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC20H23NO4 |
InChIKeyDQCKKXVULJGBQN-XFWGSAIBSA-N |
CAS Registry16590-41-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obsessive-Compulsive Disorder | Phase 2 | United States | - |